Taxotere is a cytotoxic chemotherapy drug and is the brand name for docetaxel generic form. In 1996, Sanofi-Aventis won approval for Taxotere to be marketed in the U.S. for the treatment of various cancers: breast cancer, advanced stomach cancer, head and neck cancer, non-small cell lung cancer and metastatic prostate cancer. Taxotere sales went as … [Read more...]
France Investigates Chemotherapy Drug Taxotere After Reports of Five Fatalities
Recently, the French National Drug and Health Product Safety Agency (ANSM) began an investigation of Taxotere (docetaxel) after completing a report that listed five deaths related to the chemotherapy drug. The cause of death for patients using Taxotere is neutropenic enterocolitis (also commonly referred to as typhlitis), which is the … [Read more...]
Taxotere Hair Loss Claims
If you are living with permanent hair loss (alopecia) after chemotherapy for breast cancer, Taxotere (docetaxel) may be to blame. Lawsuits allege that Taxotere maker Sanofi-Aventis knew that its drug carried the risk of causing permanent hair loss, but chose not to warn doctors or patients, in the U.S., about the danger, even while it was warning … [Read more...]
Taxotere Hair Loss Frequently Asked Questions
By Desiree Housek, Staff Writer Sanofi-Aventis, the manufacturer of Taxotere is currently being investigated for failing to adequately warn patients and physicians of the risk of permanent hair loss. Below is a list of common questions related to the Taxotere and the pending Taxotere lawsuits. What is Taxotere? Taxotere is an approved … [Read more...]
Chemo Drug Causes Unnecessary Suffering for Women Who Survive Cancer
By Sandra Dalton, Staff Writer Many women who survive breast cancer now face permanent baldness caused by a chemo therapy drug they did not have to choose. It is a side effect they were not warned about caused by Taxotere (docetaxel), which some say is inferior to its alternative in treating cancer, but more convenient to take and administer. … [Read more...]
Recent Comments